UK markets close in 4 hours 28 minutes

Tenet Healthcare Corporation (THC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
112.29+13.14 (+13.25%)
At close: 04:00PM EDT
109.71 -2.58 (-2.30%)
Pre-market: 06:33AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 11.14B
Enterprise value 21.54B
Trailing P/E 4.36
Forward P/E 17.73
PEG ratio (5-yr expected) 2.46
Price/sales (ttm)0.56
Price/book (mrq)3.23
Enterprise value/revenue 1.05
Enterprise value/EBITDA 6.36

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 363.45%
S&P500 52-week change 323.10%
52-week high 3112.30
52-week low 351.04
50-day moving average 398.52
200-day moving average 378.22

Share statistics

Avg vol (3-month) 31.22M
Avg vol (10-day) 31.56M
Shares outstanding 599.19M
Implied shares outstanding 6101.04M
Float 890.52M
% held by insiders 11.30%
% held by institutions 198.38%
Shares short (15 Apr 2024) 43.81M
Short ratio (15 Apr 2024) 44.01
Short % of float (15 Apr 2024) 44.99%
Short % of shares outstanding (15 Apr 2024) 43.84%
Shares short (prior month 15 Mar 2024) 44.44M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 42.75
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 413 Mar 2000
Last split factor 21:4
Last split date 311 Oct 2012

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 12.53%
Operating margin (ttm)15.04%

Management effectiveness

Return on assets (ttm)6.68%
Return on equity (ttm)53.69%

Income statement

Revenue (ttm)20.9B
Revenue per share (ttm)207.02
Quarterly revenue growth (yoy)8.10%
Gross profit (ttm)N/A
EBITDA 3.85B
Net income avi to common (ttm)2.62B
Diluted EPS (ttm)25.77
Quarterly earnings growth (yoy)1,404.20%

Balance sheet

Total cash (mrq)2.48B
Total cash per share (mrq)24.91
Total debt (mrq)12.88B
Total debt/equity (mrq)167.89%
Current ratio (mrq)1.44
Book value per share (mrq)34.67

Cash flow statement

Operating cash flow (ttm)2.51B
Levered free cash flow (ttm)2.51B